论文部分内容阅读
目的观察抗Hp疗法治疗萎缩性胃炎的临床效果。方法选取医院收治的Hp阳性萎缩性胃炎患者120例为研究对象,随机分为观察组和对照组,每组60例。2组采用不同类型的抗Hp疗法治疗,观察2组治疗后总有效率、Hp转阴率及用药安全性。结果经治疗后,观察组治疗总有效率为86.7%,高于对照组的71.7%(P<0.05)。观察组Hp转阴率为90.0%,高于对照组的70.0%(P<0.05)。观察组无明显不良反应发生,临床用药安全可靠。结论抗Hp疗法治疗萎缩性胃炎疗效确切,且安全可靠,值得临床上推广应用。
Objective To observe the clinical effect of anti-Hp therapy on atrophic gastritis. Methods A total of 120 Hp-positive atrophic gastritis patients admitted to hospital were selected as study subjects and randomly divided into observation group and control group, 60 cases in each group. Two groups were treated with different types of anti-Hp therapy. The total effective rate, Hp conversion rate and medication safety were observed in two groups. Results After treatment, the total effective rate in the observation group was 86.7%, which was higher than that in the control group (71.7%, P <0.05). The Hp negative conversion rate in the observation group was 90.0%, which was higher than that in the control group (70.0%, P <0.05). The observation group had no obvious adverse reactions, and the clinical medication was safe and reliable. Conclusion Anti-Hp therapy for atrophic gastritis curative effect is exact, safe and reliable, it is worth to promote clinical application.